tecovirimat will enhance the level or influence of diazepam by influencing hepatic enzyme CYP2C19 metabolism. Use Warning/Monitor. Tecovirimat is a weak inhibitor of CYP2C8 and CYP2C19. Observe for adverse consequences if coadministered with sensitive substrates of these enzymes.butabarbital will reduce the level or outcome of diazepam by impacting